BioSpace News Archive

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel combination therapy, launched their next capital raise via Community Fundraising effort to drive drug development.

Biomerica, Inc. announced that under a General Merchandise Supplier Agreement with Walmart, the Company’s Aware® Breast Self Exam device will now be sold in over 2400 Walmart’s retail stores.

Evolent Health, Inc. (NYSE: EVH) today announced it will release its third quarter 2022 operating results on Wednesday, November 2, 2022 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

Plexision, a US-based biotechnology company, has initiated overseas operations with the establishment of a reference laboratory in Hyderabad, India.

Zambon announced that the Company will present findings examining how Chronic Lung Allograft Dysfunction is the leading cause of re-transplantation and associated with high healthcare costs during a rapid oral session at the American College of Chest Physicians® 2022 Annual Meeting being held October 16 – 19, 2022 in Nashville, TN.

Maven Clinic, the world’s largest virtual clinic for women’s and family health, announced an agreement with Indira IVF to deliver high-quality fertility care to Maven members in India.

More than two years after the COVID-19 pandemic began, diagnoses of breast and prostate cancer, two of the nation’s leading causes of cancer death, continue to lag behind pre-pandemic levels, according to a nationally representative Quest Diagnostics Health Trends® study by Quest Diagnostics, the world’s leading provider of diagnostic information services.

Pacylex today announced that the U.S. Food and Drug Administration (FDA) granted PCLX-001 Orphan Drug Designation for “treatment of patients with acute myeloid leukemia.”

Indica Labs and Hamamatsu Photonics K.K. announced an agreement to maintain long-term interoperability between Indica Lab’s HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.

Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, continues to discuss the company’s RemeOs™ trauma screw market authorization with the U.S. Food and Drug Administration.